These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23591815)
1. Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1. Zhou W; Thiery JP J Cell Sci; 2013 Jun; 126(Pt 12):2740-6. PubMed ID: 23591815 [TBL] [Abstract][Full Text] [Related]
2. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
3. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. Asakura T; Yamaguchi N; Ohkawa K; Yoshida K Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863 [TBL] [Abstract][Full Text] [Related]
5. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
6. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765 [TBL] [Abstract][Full Text] [Related]
7. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Liu H; Wang H; Liu X; Yu T Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738 [TBL] [Abstract][Full Text] [Related]
8. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. Baud J; Varon C; Chabas S; Chambonnier L; Darfeuille F; Staedel C PLoS One; 2013; 8(4):e60315. PubMed ID: 23565224 [TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells. Lobert S; Graichen ME; Morris K Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119 [TBL] [Abstract][Full Text] [Related]
12. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Howe EN; Cochrane DR; Richer JK Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518 [TBL] [Abstract][Full Text] [Related]
13. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884 [TBL] [Abstract][Full Text] [Related]
14. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041 [TBL] [Abstract][Full Text] [Related]
15. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802 [TBL] [Abstract][Full Text] [Related]
16. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475 [TBL] [Abstract][Full Text] [Related]
17. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors. Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542 [TBL] [Abstract][Full Text] [Related]
18. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544 [TBL] [Abstract][Full Text] [Related]
19. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100 [TBL] [Abstract][Full Text] [Related]
20. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]